Penn Pharma Staff Complete Potent Compound Safety Training Certification through Affygility Solutions

Penn Pharma, a leading global provider of integrated drug development, clinical trial supply and manufacturing services to the international healthcare industry, today announced the completion of potent compound safety training and certification for its staff through Affygility Solutions. Penn Pharma officially opened a new purpose-built contained manufacturing facility in September 2013 and the training and subsequent certification of its staff was a critical factor milestone to achieve.

Penn Pharma selected Affygility Solutions to complete the training certification based on the specific expertise offered by Affygility Solutions in potent compound safety. Affygility Solutions also offered a unique and flexible webinar format allowing Penn Pharma staff to attend from multiple global locations. The training was extremely comprehensive and included; Introduction to Potent Compound Safety, Toxicology, Industrial Hygiene, Banding and Control Strategies and the Manufacturing of Highly Potent Compounds including both understanding and controlling the risks. This comprehensive programme along with the flexibility of training made Affygility Solutions the perfect partner for Penn Pharma.

Penn Pharma Chief Operating Officer, Mark Dean Netscher commented “We are extremely pleased to have our staff complete the potent compound safety training certification process.

“This is an important component of our continued commitment to employee safety and Operational Excellence in Penn as we continue to demonstrate leadership of the handling, development and manufacturing of potent products in our contained manufacturing facility.”

About Penn Pharma

Penn Pharma is a privately owned provider of services to the pharmaceutical and biotech industry.

Penn Pharma’s services include Formulation Development and Analytical Services, support for clinical trial studies by manufacturing and labelling investigational products for distribution to clinical sites worldwide. Penn also offers support for the importation and release of non-EU products.

Penn Pharma has specialist facilities for the supply of commercial licensed products including those requiring contained operations, protecting both operators and the environment.

Penn Pharma is inspected by many authorities allowing supply of services and products to the international market (e.g. MHRA, FDA and ANVISA) for both human and veterinary medicines.

For more information about Penn Pharma, please visit us at www.pennpharm.com

About Affygility Solutions

Affygility Solutions is a leading provider of environmental, health and safety services and software to the life sciences industry. Services provided including potent compound safety program assessments, potent compound safety training, occupational exposure limits for active pharmaceutical ingredients, and containment validation. Affygility Solutions is headquartered in Broomfield, Colorado and has clients throughout the world.